Onconetix Inc (ONCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,335 | -2,071 | -3,417 | -2,214 | -1,118 |
| Depreciation Amortization | 3 | 1 | 5 | 4 | 3 |
| Accounts receivable | N/A | -12 | -115 | -22 | -12 |
| Accounts payable and accrued liabilities | 492 | 352 | 337 | 135 | -13 |
| Other Working Capital | 835 | 1,164 | 1,215 | 735 | 400 |
| Other Operating Activity | 944 | -320 | -69 | -7 | 102 |
| Operating Cash Flow | $-4,061 | $-886 | $-2,044 | $-1,370 | $-639 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -5 | -2 | N/A | N/A |
| Purchase Of Investment | -8 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-17 | $-5 | $-2 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 25,720 | 18,400 | N/A | N/A | N/A |
| Other Financing Activity | -1,328 | -828 | -334 | -197 | 0 |
| Financing Cash Flow | $24,392 | $17,572 | $-334 | $-197 | $N/A |
| Beginning Cash Position | 1,929 | 1,929 | 4,309 | 4,309 | 4,309 |
| End Cash Position | 22,242 | 18,609 | 1,928 | 2,742 | 3,670 |
| Net Cash Flow | $20,314 | $16,681 | $-2,380 | $-1,567 | $-639 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,061 | -886 | -2,044 | -1,370 | -639 |
| Capital Expenditure | -9 | -5 | -2 | N/A | N/A |
| Free Cash Flow | -4,070 | -891 | -2,046 | -1,370 | -639 |